Recombinant FITC-Labeled Human CLEC12A/MICL/CLL-1 Protein
Beta LifeScience
SKU/CAT #: BLK-00923P-100UG
FITC-Labeled Human CLEC12A on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Recombinant FITC-Labeled Human CLEC12A/MICL/CLL-1 Protein
Beta LifeScience
SKU/CAT #: BLK-00923P-100UG
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant FITC-Labeled Human CLEC12A/MICL/CLL-1 Protein is expressed from HEK293 with His tag at the N-Terminus.It contains His65-Ala265. |
Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
Accession | Q5QGZ9 |
Target Symbol | CLEC12A/MICL/CLL-1 |
Species | Human |
Expression System | HEK293 |
Tag | N-His |
Expression Range | His65-Ala265 |
Mol. Weight | The protein has a predicted MW of 24.6 kDa. Due to glycosylation, the protein migrates to 35-55 kDa based on Tris-Bis PAGE result. |
Form | Liquid |
Formulation | Supplied as 0.22um filtered solution in PBS (pH 7.4). |
Endotoxin | Less than 1EU per ug by the LAL method. |
Storage | Valid for 12 months from date of receipt when stored at -80°C.; Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles. |
Shipping | Shipped with dry ice. |
Gene Background | CLEC12A has recently been identified as an antigen, expressed on leukemic stem cells and leukemic blasts. Given the fact that this expression profile seems stable throughout diagnosis, treatment and relapse on leukemic blasts and leukemic stem cells, CLEC12A can be considered a highly potent and reliable marker for the detection of measurable residual disease and therefore applicable for risk stratification and prognostication in AML. |